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Abstract
The importance of linking evidence into practice and policy is recognised as a key pillar of a prudent approach to
healthcare; it is of importance to healthcare professionals and decision-makers across the world in every speciality.
However, rapid access to evidence to support service redesign, or to change practice at pace, is challenging. This is
particularly so in smaller specialties such as Palliative Care, where pressured multidisciplinary clinicians lack time and
skill sets to locate and appraise the literature relevant to a particular area. Therefore, we have initiated the Palliative
Care Evidence Review Service (PaCERS), a knowledge transfer partnership through which we have developed a
clear methodology to conduct evidence reviews to support professionals and other decision-makers working in
palliative care.
PaCERS methodology utilises modified systematic review methods as there is no agreed definition or an accepted
methodology for conducting rapid reviews. This paper describes the stages involved based on our iterative recent
experiences and engagement with stakeholders, who are the potential beneficiaries of the research. Uniquely, we
emphasise the process and opportunities of engagement with the clinical workforce and policy-makers throughout
the review, from developing and refining the review question at the start through to the importance of
demonstrating impact. We are faced with the challenge of the trade-off between the timely transfer of evidence
against the risk of impacting on rigour. To address this issue, we try to ensure transparency throughout the review
process. Our methodology aligns with key principles of knowledge synthesis in defining a process that is
transparent, robust and improving the efficiency and timeliness of the review.
Our reviews are clinically or policy driven and, although we use modified systematic review methods, one of the
key differences between published review processes and our review process is in our relationship with the
requester. This streamlining approach to synthesising evidence in a timely manner helps to inform decisions faced
by clinicians and decision-makers in healthcare settings, supporting, at pace, knowledge transfer and mobilisation.
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Background
Evidence-based medicine involves the integration of the
best research evidence with clinical expertise and a pa-
tient’s unique values and circumstances. It is an ap-
proach to care that encourages clinicians to use the best
available evidence in combination with the individual pa-
tient’s circumstances [1]. The importance of putting evi-
dence into practice and policy has been a focus for
decades within health and social care as well as other
topic areas. However, there are barriers to the uptake of
evidence amongst policy-makers and clinicians, includ-
ing a lack of confidence, knowledge and time [2–5]. This
is particularly the case in smaller specialties such as pal-
liative care, where pressured multidisciplinary clinicians
often lack the time and/or skill sets to locate and ap-
praise vast amounts of literature in a timeframe that
aligns with clinical and service need [6, 7]. Resultant
opportunity costs include inadequate underpinning of
policy and operational decision-making, and lost oppor-
tunities to engage the clinical workforce with research as
part of practice.
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In recent years, rapid reviews have emerged as an effi-
cient approach to synthesising evidence. They represent
an alternative approach to systematic reviews that can
be time-consuming, resource-intensive and costly, and
may take on average from 6 months to several years [8–
10]. This paper describes the approach used by the Pal-
liative Care Evidence Review Service (PaCERS), based
within the Wales Cancer Research Centre and funded by
Health and Care Research Wales. The aim of the service
is to provide clinicians, services and policy-makers with
timely access to relevant reviews of research evidence, in
support of at-pace changes to clinical practice.
Rapid reviews aim to align more closely with decision
timelines and to use methodology that expedites ele-
ments of the review process. However, this must be in a
manner that is scientifically robust, transparent and re-
producible. Although rapid reviews are increasingly
prevalent, there is no accepted standardised method-
ology nor an agreed definition [11–13]. In our method-
ology, we used the following definition, where a “[r]apid
review is defined as a review conducted within 8-10
weeks using modified systematic review methods with a
highly refined research question, search carried out
within limited set of databases and other sources and in-
creasing the transparency of our methodology and expli-
citly summarising it for each review” [14].
In the academic literature, various terms are used to
describe rapid reviews. In an international survey of
rapid review producers that took place in 2015, the
terms used included ‘evidence briefs’, ‘rapid evidence
synthesis’, ‘rapid systematic review’ and ‘health technol-
ogy assessment’ [13]. In view of the range of terms and
current practices, and in keeping with the need for
transparency in adhering to key principles of knowledge
synthesis [15], we set out to describe a methodology that
provides a standardised and explicit framework for con-
ducting rapid reviews of relevance to our specialty work-
force. This approach delivers a detailed critique of the
available literature and is presented in a stratified way
for ease of access to meet stakeholder needs.
Our reviews are clinically driven and, although we are
using modified systematic review methods, one of the
main differences between published review processes
and a PaCERS rapid review is in our relationship with
the requester. We work in partnership with palliative
care professionals to find the evidence they need to sup-
port changes to their clinical practice. The only reviews
conducted are those requested by clinicians or decision-
makers. Therefore, we carry out reviews on topics of im-
mediate relevance to clinical practice, with the purpose
to save time and resources for clinical teams and provide
information in a useful format that can be implemented
at pace. We encourage the requesters to remain involved
where possible in the review process and offer training
in the review methods. By only undertaking reviews in
topic areas of immediate relevance to services and
policy-makers, we aim to increase the potential for rapid
impact on patient care and to more immediately engage
the workforce with the value of research. In PaCERS, we
foster a relationship between researchers and practi-
tioners to translate and communicate evidence into
practice.
Methodology
As already indicated, PaCERS uses modified systematic
review methods to produce information in a timely man-
ner, while retaining rigour according to established sys-
tematic review methodology [16]. A Review Advisory
Group (RAG) was set up to help the review team deter-
mine the constraints of a proposed review and to pro-
vide input relating to the review question and its
relevance to policy and practice. The RAG consists of
five members who have expertise in palliative medicine,
systematic reviews and research methods as well as pa-
tient and public involvement research partners. The
RAG is a fixed group that provides expertise and advice
for the process of each review. Their scope is based on
the criteria used for selecting rapid review projects and
the 1-day workshop held to engage with stakeholders.
An overview of our process is outlined in Fig. 1.
A 1-day workshop was held in December 2015 for
stakeholders in Wales to get a consensus on how
PaCERS can best serve the palliative care community in
conducting rapid reviews.
The workshop consisted of the following three
sessions:
 Session 1: making a request – getting a format that
makes sense
 Session 2: what would the results look like?
 Session 3: what does impact look like?
Common themes emerged (e.g. transparent reporting
of the methods, tabulate results, provide key findings
earlier in the report, use lay language), which gave us a
better understanding of stakeholders’ interests and atti-
tudes towards the service. This influenced key elements
of our review process, in particular the structure for
requesting reviews, opportunities for engagement in the
review process and the structure of our reporting tem-
plate. Structuring results for stakeholders is essential to
facilitate the translation of findings into healthcare prac-
tice or policy.
Stage 1: engaging with requesters and identifying the
need for evidence
The PaCERS approach to engaging clinicians and service
users varies (Fig. 2). Our aim is to engage with the
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clinical workforce, policy-makers and across NHS orga-
nisations to undertake high quality reviews directly rele-
vant to patient and carer needs. This enables us to close
the gap between research and practice, which can be
achieved through an active and engaged partnership.
Our rapid review is driven by the information captured
in the rapid review request form. The request form
reflects the elements found in a research protocol and
acts as a guide for members of the review team. For a
copy of the form, see Additional file 1. When a research
question is raised, the request form is sent for comple-
tion, and this acts as the protocol to develop the rapid
review. According to the PRISMA-P (Preferred Report-
ing Items for Systematic review and Meta-Analysis
Fig. 1 An overview of PaCERS review process
Mann et al. Health Research Policy and Systems          (2019) 17:100 Page 3 of 9
Protocols) 2015 checklist [17], it is recommended that
protocols for systematic reviews or rapid reviews should
be registered with PROSPERO, which is an international
database of prospectively registered systematic reviews
in health and social care [18]. To date, we have only reg-
istered our protocols where the review has been part of
an MSc thesis with the aim to publish the review in an
academic journal. However, going forward, our intention
is to register all our review protocols.
Upon receipt of the request form, the first task is to
check that the question is in scope with important clin-
ical palliative care priorities, for example, the End of Life
Care Delivery Plan for Wales [19], associated strategic
health priorities and/or research priority exercises such
as the JLA Palliative and End of Life Care Priority Set-
ting Partnership [20]. Where more than one concurrent
request is made, the RAG will prioritise based on these
criteria (Table 1).
Once the request form has been reviewed by RAG
and is accepted, the next stage is to engage the re-
quester in detailed discussion of the question. Ques-
tions posed are often very broad and lack description.
Therefore, developing the question in partnership
with the requester is crucial in defining the search
strategy and improving the efficiency and timeliness
of the review. We have found that the discourse be-
tween the review team and the requester at this early
stage is important, not only in improving efficiency,
but in providing teaching and training opportunities
to clinical staff in review methods and developing a
wider conversation within clinical teams about re-
search engagement.
Stage 2: defining the review process
As the team work closely with the requester to refine
the wording and scope of the original question, it helps
to establish the inclusion/exclusion criteria and develop
the scoping search.
This process is often iterative and involves defining
the elements of the question that enable the team to de-
velop the search strategy. For effectiveness questions, the
PICO (Population, Intervention, Comparison, Out-
comes) framework [21] is used; for qualitative questions,
the SPICE (Setting, Perspective, Intervention/phenom-
ena of interest, Comparison, Evaluation) framework is
recommended [22].
In many question formulation sessions, we have rea-
lised that these are not rigid frameworks to adhere to as
some components are not relevant to the question.
However, they provide structure to the iterative process
of discussing and clarifying just what the research ques-
tion will and will not find. Consequently, with every re-
view question, we try to structure it using PICO or
SPICE; even using only part of a framework helps to
focus and facilities the literature search. Throughout the
process, our ongoing communication with the end users
ensures that the review is fit-for-purpose and actionable.
Synthesising evidence in the midst of complexity is
challenging. Some review questions have been difficult
to define, as has been the interpretation of how the
intervention relates to the outcomes. Therefore, in deal-
ing with complex interventions, the use of logic models
may assist in describing the various components of in-
terventions and the relationships between them and
Fig. 2 PaCERS approach to engaging clinicians and service users
Table 1 Criteria used for selecting rapid review projects
• Research questions or evidence uncertainties identified and prioritised
by health and social care professionals in Wales
• Research question directly relevant to patient and carer needs and
readily translated into improvements in care
• Alignment with either End of Life Care Delivery Plan for Wales or JLA
Palliative and End of Life Care Priority Setting Partnership
• Justification by requesters that topic areas will bring noticeable
benefits and evidence-based treatments to a sizable patient population
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outlining interactions between the intervention and the
system within which it is implemented [23–26]. Al-
though logic models are often used in designing, evaluat-
ing and planning programme management and policy,
we have found that this approach can help define eligi-
bility criteria and search terms once the question has
been refined, and we intend to explore this approach in
future questions involving complex interventions. To
date, we have only used it for one review, see example in
Additional file 2.
Once the question is developed, prior to carrying out
the search, we try to identify whether there are already
existing systematic reviews available to answer the re-
search question by searching the evidence sources such
as the Cochrane Database of Systematic Reviews, using
the topic of the rapid review; PubMed Clinical Queries,
using a systematic reviews filter; and PubMed searching
with the rapid review topic and the term ‘systematic
reviews’.
Stage 3: searching for information
We have developed a set of search terms relating to pal-
liative care and cancer with input from a subject librar-
ian working in a cancer research library on Ovid
Medline (Table 2). Therefore, the only search terms that
need to be identified are the terms relating to the other
component of the research question, e.g. intervention or
exposure, phenomena of interest, comparison or
outcome.
The search strategy is developed and conducted ini-
tially in Ovid Medline. The first 20 references are sent to
the requester to check for any relevant studies. At this
stage, the search strategy often needs to be refined if
relevant studies are not identified. Once the strategy is
finalised, the search is executed across key databases and
other sources. At least six databases and supplementary
sources are selected as relevant to the topic (Table 3).
We identify potential sources to search depending on
the scope of the question. Additionally, we test key pa-
pers to see if they are retrieved in the database combin-
ation. Grey literature sites are identified via the RAG or
by the requester themselves. Experience to date has
highlighted that high-quality quantitative data is not
often abundant for the types of questions posed. There-
fore, searches are carried out for all types of research
studies without limiting to any specific study design.
Where systematic reviews or randomised controlled
trials are not available, we will examine evidence from
case series (≥25 patients only), case control studies, co-
hort studies or qualitative studies. Furthermore, where
the review question is so specific and the research is lim-
ited, we have sought to include conference abstracts and
extract data from service evaluations. The data sources
are explicitly described in the report and analysed for
quality.
The generic time limit that we employ across our
rapid review search is the last 10 years, searching for
studies published in Organisation for Economic Co-
operation and Development (OECD) countries [27] and
in English language only. We exclude doctoral disserta-
tions and book chapters. Checking of reference lists of
Table 2 Search strategy for Ovid Medline search strategy for
palliative care and cancer
1. Palliative care/
2. Terminal Care/
3. Terminally ill/
4. Hospice care/
5. (“palliative care” or “supportive care” or “hospice care” or “end of life
care”).tw.
6. ((hospice or terminal*) adj3 (care or caring or ill*)).tw.
7. (“last year of life” or LYOL or “end of life” or “end of their lives”).tw.
8. (end-stage disease* or end stage disease* or end-stage ill* or end
stage ill*).tw.
9. or/1–8
10. exp. Neoplasms/
11. (cancer* or oncolog* or neoplasm* or carcinom* or tumo?r* or
malignan* or Leukemia* or lymphoma* or leukaemia*).tw.
12. 10 or 11
13. 9 or 12
Table 3 Bibliographic databases
Database Database
platform
CINAHL Ebsco
Cochrane CENTRAL Wiley
EMBASE Ovid
Health Management Information Centre Ovid
The Joanna Briggs Institute Evidence-Based Practice
Database
Ovid
Medline Ovid
PsycINFO Ovid
Scopus Thomas Reuters
Web of Science Clarivate
Analytics
Supplementary Sources
Google Scholar – Citation tracking via Google Scholar is carried out
depending on the time available.
Electronic Table of Content of Key Journals (search minimum of two
journals for last two years in relation to appropriate subject area). Key
journals to hand search are selected by the requester.
Grey Literature – Websites relevant to the topic area are searched, e.g.
National Cancer Research Institute, The National Gold Standards
Framework (GSF) Centre in End of Life Care, The Social Care Institute for
Excellence (SCIE), INVOLVE Evidence library, European Association for
Palliative care and Google.
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included studies enables us to identify any relevant stud-
ies that may have been published prior to our specified
date range.
In addition to searching bibliographic databases, we
carry out supplementary searching to identify unpub-
lished research or research reported in the grey litera-
ture. We search relevant websites and the electronic
table of contents of key journals for the past 2 years and
scan the reference list of included studies and systematic
reviews.
An adapted version of the PRISMA flow diagram [28]
is used to represent the flow of information through the
different phases of the review.
Stage 4: study selection process
The search results are imported into the reference man-
agement database Endnote. Study selection by the review
team is directed by eligibility criteria documented in the
request form as agreed with the requester. The title and
abstract screening stage of study selection is carried out
by two reviewers independently. References with the de-
cision ‘yes’ or ‘maybe’ are then retrieved in full text to be
examined for eligibility.
Secondly, scanning of the full-text studies is carried
out by one reviewer and checked by a second. If ex-
cluded, reasons for exclusion are recorded. At the full
text stage, a record is kept in an Excel spreadsheet as to
the reason for exclusion. Any discrepancies are resolved
by discussion or with involvement of a third reviewer.
Stage 5: extracting data
Data extraction forms vary from review to review since
the extraction forms are tailored to the review question
and the eligibility criteria documented in the request
form. We pilot and refine the form to ensure that all the
relevant information is captured.
Data extraction is carried out by one reviewer for all
eligible studies. All data are then checked against the
original article by a second reviewer. Any discrepancies
are resolved by discussion or with involvement of a third
reviewer.
The data captured on the data extraction forms dir-
ectly informs the study characteristics table in the pub-
lished review. For an example data extraction form see
Additional file 3.
Stage 6: appraising data
During the quality appraisal stage, the evidence is
reviewed for its relevance, validity and results for the
specific question. We assess the internal and external
validity, checking the strengths and weaknesses for each
paper.
In our reviews, quality assessment of the eligible stud-
ies is carried out by one reviewer and checked by
another reviewer using appropriate quality assessment
checklists. Any disagreements are resolved by discussion
with the third reviewer to reach a consensus. We have
adopted an amended version of the GATE checklist
(Graphic Appraisal Tool for Epidemiological studies)
[29] for which we requested permission from Professor
Rod Jackson from the Section of Epidemiology & Bio-
statistics at the School of Population Health, Faculty of
Medical and Health Sciences, University of Auckland,
New Zealand. The main components we use from the
GATE checklist are the study design, internal validity,
study results and external validity components. We have
also been using the Specialist Unit for Review Evidence
(SURE) Cardiff University critical appraisal checklists;
this set of checklists can be used for quality assessment
of a range of different study types [30]. If several papers
are found to be related to one study, these papers are
grouped and only the one study is identified for quality
appraisal [31].
For copies of the quality assessment checklist see Add-
itional files 4 and 5.
Stage 7: summarising and communicating the evidence
In order for evidence to be useful and accessed for
decision-making, it must be summarised in a user-
friendly format [32–34]. The challenges faced by clini-
cians, nurses and other professionals engaging with
evidence-based practice is reported in the literature. The
most common barriers stated are the lack of resources,
lack of time, research barriers and lack of knowledge [3,
5, 35–37].
At the outset, when the service was established, our
aim was to communicate the answer to a research ques-
tion in a coherent manner. Although rapid review report
formats vary greatly (e.g. from generation of a reference
list through to detailed appraisal) we wished to develop
a format that was explicit and comprehensive, minimis-
ing clinician time and resource in receiving and under-
standing the information retrieved. Our review format
was informed and approved by end users at our initial
workshop as being presented in a consistent and easy to
read format, consisting of (1) review methods and con-
text; (2) key findings split into three areas documenting
reliability, consistency and relevance of evidence; (3) evi-
dence implications in relation to both clinical and policy
decisions; (4) PRISMA flow diagram, showing the flow
of information; (5) tables of study summaries (we used
the Scottish Intercollegiate Guidelines Network (SIGN)
considered judgement checklist [38] for summarising the
findings from each study, these include study objective,
participants, interventions/comparators/methods, out-
comes summary of the study results and appraisal sum-
mary); and (6) a list of included studies, bibliographic
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records and details of additional information available
on request.
The reviews are added to the PaCERS rapid review re-
pository, which sits within the Palliative and Supportive
Care Research website [14]. When a new review is
published, it is communicated via email to healthcare pro-
fessionals and other decision-makers working in palliative
care throughout Wales. In addition, findings have been
presented at international and national conferences, where
the feedback has been positive. See Additional file 6.
As William Pollard said, “Information is a source of
learning. But unless it is organized, processed, and avail-
able to the right people in a format for decision-making,
it is a burden, not a benefit” [39]. Therefore, we have re-
solved not only to produce the evidence in a user-
friendly format but also for it to be easily accessible.
Stage 8: demonstrating impact
Our project funders, the Wales Cancer Research Centre,
just like any other research funders, expect the service to
demonstrate impact. Within our request form, the ques-
tion ‘Will you be able to identify and feedback to us on
the impact the review has had?’ is presented. Therefore,
from the very start, the requester is expected to provide
feedback. When the review is completed, we send the re-
questor a feedback form to document the impact of the
review in the weeks and months that follow, e.g. how the
review was used to inform clinical practice/care
provision. We cannot control impact, but we try to en-
courage ‘uptake’ of the research evidence, especially as
PaCERS reviews are clinician led and clinically driven.
For a copy of the Impact form see Additional file 7.
Discussion
To date, we have carried out eight reviews (listed below),
which are published on our Palliative and Supportive
Care Research website. All reviews aim to facilitate
knowledge transfer in areas of current relevance to clini-
cians, maximising the opportunity for new knowledge to
be mobilised and implemented.
In addition, the reviews impact on conversations be-
tween researchers, clinicians and patients about the type
of evidence needed, how to choose this and how to im-
plement it to provide the right care. We have had inter-
est from clinicians in palliative care eager to improve or
change clinical practice as well as from End of Life
Boards commissioners requesting rapid reviews to in-
form recommendations for service improvements in pal-
liative care. Identification of knowledge gaps acts as a
driver of reverse translation in generating new
hypothesis-driven clinical studies. The rapid reviews
conducted to date have addressed the following
questions:
1. What are best practice service models in rural areas
for the delivery of end of life and palliative care?
2. Does advance care planning alter management
decisions made by healthcare professionals?
3. What processes decrease the risk of opioid toxicity
following interventional procedures for
uncontrolled pain in palliative care or cancer
patients?
4. What outpatient models have proven efficacy for
assessment and management of pelvic radiotherapy
late effects?
5. What is the impact and effectiveness of the 7-day
Clinical Nurse Specialist service on palliative care
patients and their families?
6. What are the models and outcomes of public and
patient involvement in cancer and palliative care
research?
7. What are the perceptions about oxygen use in
patients with pulmonary fibrosis and their carers?
8. What is the evidence base for the assessment and
management of cancer cachexia in adults with
incurable pancreatic cancer?
In PaCERS, we have attempted to incorporate a core
principle of Prudent Healthcare in using evidence-based
approaches to reduce inappropriate variation in care
whilst using that process to facilitate the principle of
“achieving health and wellbeing with the public, patients
and professionals as equal partners through co-
production”. There is potential for rapid impact when
working in partnership through co-production with
shared purpose and commitment.
As mentioned at the outset, there is no definitive
methodology for conducting rapid reviews. In 2015,
Cochrane, the global network and producer of high-
quality systematic reviews of effectiveness, established
the Cochrane Methods Rapid Reviews Group. Their
scope was to inform rapid review methodology both
within the Cochrane Collaboration and beyond. At the
group’s first Colloquium open meeting in Seoul in Octo-
ber 2016, MM had the opportunity to present on the
progress of PaCERS methodology. There are several
healthcare organisations across the world producing
rapid reviews using various methods in order to deliver
evidence in a timely manner [38, 40–42]. As a result,
there are many publications on various aspects of their
methods [4, 10, 12, 43–47]. It is clear that the scope,
methodology and timeline for conducting reviews differ.
Conclusions
The PaCERS methodology aligns with key principles of
knowledge synthesis in defining a process that is transpar-
ent and robust. By definition, the review process aims to
shorten the steps of established systematic review methods,
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whilst ensuring rigour in avoiding bias during the stages of
study selection, quality assessment and synthesis.
Key components of our methodology are the insist-
ence on only undertaking reviews nominated by clinical
services and policy-makers, and our direct involvement
of the requester in review development. Use of this ap-
proach attempts to maximise the direct and current rele-
vance of the evidence base to practice and the efficient
production of actionable, fit-for-purpose reviews. It also
creates opportunity for training in appraisal and review
methods amongst a multi-professional workforce, and
the facilitation of dialogue around the utility of research
to clinical practice.
Additional strengths include our consensus approach to
refinement of data extraction and evidence quality tem-
plates depending on the review question, and the degree to
which the requester can be involved in the process whilst
minimising the risk of bias. Within our review process, we
attempt to work in partnership with the requester. This in-
cludes developing the question and checking the relevance
of the initial search and study selection. In order to minim-
ise potential for bias, one of the researchers from the review
team is involved in every stage of the review.
We acknowledge that there are limitations within our
process. We are faced with the challenge of the trade-off
between the timely transfer of evidence against the risk
of impacting on rigour [48]. To address this issue, we try
to ensure transparency throughout the review process.
Our search is not as comprehensive as full systematic
reviews since we only search for the last 10 years, in
OECD countries and in the English language. Our qual-
ity assessment and data extraction are carried out by one
reviewer and checked by another reviewer. Even though
we are not carrying out quality assessment or data ex-
traction independently, our methods are still stringent
compared to other rapid review methods.
Due to the nature of some review questions, it has been
necessary for those reviews to include service evaluations.
As it is not possible to undertake quality assessment on
evaluation papers, we have chosen to accept the papers to
be included in the review, with a narrative commentary
on their limitations. We are confident, however, that our
reporting template, co-produced with clinical and aca-
demic colleagues, allows explicit recognition of these limi-
tations whilst providing evidence in a format that is easily
accessed, understood and actionable.
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